Directory of Cyclotrons used for Radionuclide Production in Member ...

18 F RADIONUCLIDE PRODUCTION
Production Typical
production
yield (GBq)
176 182
% Isotopic
enrichment
18 O used
Target Volume Usage/year Do you
recycle
18 OH2?
18 OH2
18 O2
18 OH2 (g)
18 O2 (l)
18 O (p, n) 18 F 100 95 1.5 ml Yes
No
Ne (d, α) 18 F
16 O (α, x) 18 F
18 F RADIOPHARMACEUTICALS PRODUCED
Name
Yield on batch Frequency of Used on site Distribution/
(list)
(GBq)
production
sales
18
FDG 50 Yes No X Yes X No
Yes No Yes No
Yes No Yes No
Yes No Yes No
11
C RADIOPHARMACEUTICALS PRODUCED
Name
Yield on batch Frequency of Used on site Distribution/
(list)
(GBq)
production
sales
Yes No Yes No
Yes No Yes No
Yes No Yes No
Yes No Yes No
13 N RADIOPHARMACEUTICALS PRODUCED
Name
(list)
Typical yield on
batch (GBq)
15 O RADIOPHARMACEUTICALS PRODUCED
Name
(list)
Frequency of
production
Nuclear reaction used Distribution/
sales
Yes No
Yes No
Yes No
Typical yield on batch (GBq) Frequency of production Nuclear reaction
used
Price/
GBq
Price/
GBq
Price/
GBq
Price/
GBq
OTHER ISOTOPES PRODUCED
Name
Yield on batch Frequency of Used on site Distribution/ Price/
(list)
(GBq)
production
sales
GBq
64
Cu < 1 2/month Yes X No Yes X No
67
Ga Yes No Yes No
86
Y Yes No Yes No
94m
Tc Yes No Yes No
103
Pd Yes No Yes No
111
In Yes No Yes No
123
I
Yes No Yes No
124
I
Yes No Yes No
201
Tl Yes No Yes No
211
At < 1 1/month Yes X No Yes X No
[17] COMMENTS: (e.g., you may add names of additional labelled compounds/radiopharmaceuticals being produced)
18
F-FDG production in collaboration with commercial partner that is in charge with distribution
(commercial data confidential) proton therapy: test and development of beam diagnostic equipment in collaborations
64 211
Cu and At: target development, alternative production routes, production capacity will increase
Distribution of 64 Cu and 211 At to collaboration partners in the nuclear and medical field for in vitro (later in vivo) studies;
studies with 211At have to start in our labs due to missing licenses for handling alpha-emitters in hospitals
CPAA for biokinetics studies on radioactive fallout components
TLA for release studies on biomedical materials and implants, as well as engine components